Algert Global’s AbbVie ABBV Stock Holding History

Algert Global’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Sell	7,917 -104	-1%	-$22.4K	0.02%	831
2026 Q1	$1.74M	Sell	8,021 -2,170	-21%	-$481K	0.03%	743
2025 Q4	$2.33M	Buy	10,191 +1,443	+16%	+$329K	0.04%	674
2025 Q3	$2.03M	Buy	8,748 +16	+0.2%	+$3.26K	0.03%	687
2025 Q2	$1.62M	Sell	8,732 -454	-5%	-$84.4K	0.03%	693
2025 Q1	$1.92M	Buy	9,186 +1,264	+16%	+$246K	0.05%	611
2024 Q4	$1.41M	Buy	7,922 +651	+9%	+$120K	0.03%	710
2024 Q3	$1.44M	Buy	+7,271	New	+$1.36M	0.04%	669
2023 Q3	–	Sell	-2,097	Closed	-$283K	–	1088
2023 Q2	$283K	Hold	2,097	–	–	0.01%	922
2023 Q1	$334K	Hold	2,097	–	–	0.02%	922
2022 Q4	$339K	Hold	2,097	–	–	0.02%	909
2022 Q3	$281K	Buy	+2,097	New	+$301K	0.02%	961
2019 Q4	–	Sell	-5,396	Closed	-$409K	–	372
2019 Q3	$409K	Sell	5,396 -1,624	-23%	-$111K	0.15%	178
2019 Q2	$510K	Buy	+7,020	New	+$552K	0.19%	168

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Algert Global's ABBV Position: Q2 2026 in Review

Algert Global reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $22.4K and leaving 7,917 shares worth $1.99M. The position accounts for 0.02% of the portfolio, ranked #831.

Algert Global first reported a position in ABBV in Q2 2019 and has held it in 14 quarters since. The position peaked at $2.33M in Q4 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Algert Global held 7,917 shares of AbbVie worth $1.99M as of Q2 2026.
Algert Global sold 104 AbbVie shares in Q2 2026, an estimated $22.4K.
AbbVie made up 0.02% of Algert Global's portfolio in Q2 2026, its #831 holding.
Algert Global first reported a position in AbbVie in Q2 2019 and has held it in 14 quarters since.
Algert Global's AbbVie position peaked at $2.33M in Q4 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.